HKD 1.12
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 126.38 Million CNY | -45.11% |
2022 | 150.72 Million CNY | 114.13% |
2021 | -1.39 Billion CNY | -54.7% |
2020 | -909.23 Million CNY | -667.52% |
2019 | -122.46 Million CNY | -943.99% |
2018 | -17.45 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -5.55 Million CNY | 0.0% |
2024 Q1 | -5.55 Million CNY | 63.03% |
2023 Q3 | -15.03 Million CNY | -735.49% |
2023 FY | - CNY | -45.11% |
2023 Q4 | -15.03 Million CNY | 0.0% |
2023 Q2 | -1.79 Million CNY | 0.0% |
2023 Q1 | -1.79 Million CNY | -113.47% |
2022 Q4 | 13.35 Million CNY | 0.0% |
2022 Q2 | 24.38 Million CNY | 0.0% |
2022 Q1 | 24.38 Million CNY | 69.95% |
2022 FY | - CNY | 114.13% |
2022 Q3 | 13.35 Million CNY | -45.23% |
2021 Q1 | 17.57 Million CNY | -29.62% |
2021 FY | - CNY | -54.7% |
2021 Q2 | 17.57 Million CNY | 0.0% |
2021 Q4 | 14.35 Million CNY | 0.0% |
2021 Q3 | 14.35 Million CNY | -18.35% |
2020 Q4 | 24.97 Million CNY | 0.0% |
2020 Q1 | 27.61 Million CNY | 0.0% |
2020 FY | - CNY | -667.52% |
2020 Q3 | 24.97 Million CNY | -9.58% |
2020 Q2 | 27.61 Million CNY | 0.0% |
2019 FY | - CNY | -943.99% |
2018 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | 68.84 Million HKD | -83.565% |
UMP Healthcare Holdings Limited | 161.98 Million HKD | 21.978% |
Human Health Holdings Limited | 104.06 Million HKD | -21.445% |
EuroEyes International Eye Clinic Limited | 292.1 Million HKD | 56.734% |
Kato (Hong Kong) Holdings Limited | 133.61 Million HKD | 5.411% |
Bamboos Health Care Holdings Limited | 52.75 Million HKD | -139.549% |
Beijing Health (Holdings) Limited | -44.19 Million HKD | 385.988% |
C-MER Eye Care Holdings Limited | 359.88 Million HKD | 64.883% |
Town Health International Medical Group Limited | 53.5 Million HKD | -136.222% |
Medicskin Holdings Limited | 6.77 Million HKD | -1765.127% |
Hang Chi Holdings Limited | 81.58 Million HKD | -54.903% |